WC
VRXAW

Wealthspring Capital’s Veraxa Biotech AG Warrants VRXAW Stock Holding History

Wealthspring Capital’s Portfolio VRXAW Stock Details VRXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
+185,330
New +$32.7K ﹤0.01% 201

Other funds holding VRXAW

CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Wealthspring Capital's VRXAW Position: Q2 2026 in Review

Wealthspring Capital opened a new position in Veraxa Biotech AG Warrants (VRXAW) in Q2 2026: 185,330 shares worth $20.4K. The stake represents ﹤0.01% of the portfolio and ranks #201 among its holdings.

26 funds tracked by Wall St. Rank hold VRXAW as of Q2 2026.

  • Wealthspring Capital held 185,330 shares of Veraxa Biotech AG Warrants worth $20.4K as of Q2 2026.
  • Veraxa Biotech AG Warrants was a new Wealthspring Capital position in Q2 2026.
  • Veraxa Biotech AG Warrants made up ﹤0.01% of Wealthspring Capital's portfolio in Q2 2026, its #201 holding.
  • 26 funds tracked by Wall St. Rank held Veraxa Biotech AG Warrants as of Q2 2026.

Based on Wealthspring Capital's 13F filing for Q2 2026, filed 15 Jul 2026.